BIOMAT Database Logo BIOMAT Database Logo

Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine. 1990

G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey 17033.

The disposition of a single intravenous dose of 14C-nicotine was investigated in six cigarette smokers and six nonsmokers. Plasma and urinary elimination of both nicotine and cotinine was faster in smokers than in nonsmokers. In the urine of both smokers and nonsmokers, we identified nicotine and eight metabolites, including two new metabolites: metabolite A (3-hydroxycotinine glucuronide) and metabolite G (demethylcotinine delta 2',3'-enamine). Metabolites A and G were of particular interest because, in smokers, they both persisted longer than cotinine. This property renders them more sensitive than cotinine as potential indicators of passive exposure to cigarette smoke.

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003367 Cotinine The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties. Scotine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D014028 Tobacco Smoke Pollution Contamination of the air by tobacco smoke. Air Pollution, Tobacco Smoke,Environmental Pollution, Tobacco Smoke,Passive Smoking,Smoking, Passive,Environmental Smoke Pollution, Tobacco,Environmental Tobacco Smoke Pollution,Involuntary Smoking,Second Hand Smoke,Secondhand Smoke,Secondhand Smoking,Hand Smoke, Second,Hand Smokes, Second,Involuntary Smokings,Passive Smokings,Pollution, Tobacco Smoke,Pollutions, Tobacco Smoke,Second Hand Smokes,Secondhand Smokes,Secondhand Smokings,Smoke Pollution, Tobacco,Smoke Pollutions, Tobacco,Smoke, Second Hand,Smoke, Secondhand,Smokes, Second Hand,Smokes, Secondhand,Smoking, Involuntary,Smoking, Secondhand,Smokings, Involuntary,Smokings, Passive,Smokings, Secondhand,Tobacco Smoke Pollutions

Related Publications

G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.
March 1993, Clinical pharmacology and therapeutics,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.
August 1989, American journal of public health,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers.
January 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
[Plasma determinations of nicotine and cotinine: biological markers of tobacco in smokers and nonsmokers].
November 1990, Medicina clinica,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Saliva cotinine levels in smokers and nonsmokers.
February 2000, American journal of epidemiology,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Cotinine in seminal fluids of smokers, passive smokers and nonsmokers.
January 1997, Le Journal medical libanais. The Lebanese medical journal,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Codeine disposition in smokers and nonsmokers.
August 1982, Clinical pharmacology and therapeutics,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Phenytoin disposition in smokers and nonsmokers.
November 1978, International journal of clinical pharmacology and biopharmacy,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Evaluation of Urinary Btex, Nicotine, and Cotinine as Biomarkers of Airborne Pollutants in Nonsmokers and Smokers.
January 2015, Journal of toxicology and environmental health. Part A,
G A Kyerematen, and M L Morgan, and B Chattopadhyay, and J D deBethizy, and E S Vesell
Differentiating between smokers and nonsmokers using serum cotinine.
August 2019, Biomarkers in medicine,
Copied contents to your clipboard!